(Q50736148)

English

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.

scientific article published in May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Andreas Lundqvist

7

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Takehito Igarashi

object named as

Takehito Igarashi

6

0 references

author name string

Ramaprasad Srinivasan

1

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Yoshiyuki Takahashi

2

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

J Philip McCoy

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Igor Espinoza-Delgado

4

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Colleen Dorrance

5

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

A John Barrett

8

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Neal S Young

9

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Nancy Geller

10

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Richard W Childs

11

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

133

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

305-314

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Natural history of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Current status of allogeneic bone marrow transplantation in acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Bone marrow transplants for paroxysmal nocturnal haemoglobinuria.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Long-term outcome after bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06019.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2006.06019.X

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/16643433

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50736148&oldid=1108091637"